Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerwin Huls

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
Hemasphere|September 18, 2023
Clonal Hematopoiesis Defined by Somatic Mutations Infrequently Co-occurs With Mosaic Loss of the Y Chromosome in a Population-based CohortPriscilla Kamphuis, Isabelle A van Zeventer, Aniek O de Graaf, et al.
Haematologica|December 11, 2025
Potent synergy of DHODH and SREBP inhibition in acute myeloid leukemia via disruption of cholesterol and lipid metabolismShanna M Hogeling, Dominique Sternadt, Nikita La Rose, et al.
Transplantation and Cellular Therapy|May 13, 2024
Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune SuppressionLinde M Morsink, Carin L E Hazenberg, Goda Choi, et al.
Leukemia Research|April 8, 2019
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patientsJacobien Hilberink, Carin Hazenberg, Eva van den Berg, et al.
Cancer Cell|May 5, 2023
Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general populationIsabelle A van Zeventer, Aniek O de Graaf, Jonas B Salzbrunn, et al.
Experimental Hematology & Oncology|March 30, 2024
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responsesYusheng Lin, Ghizlane Choukrani, Lena Dubbel, et al.
Plos Medicine|June 7, 2019
Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort studyMichele F Eisenga, Maarten A De Jong, Peter Van der Meer, et al.
Blood Advances|August 30, 2021
Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortalityIsabelle A van Zeventer, Aniek O de Graaf, Melanie M van der Klauw, et al.
Plos One|March 1, 2018
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approachMathilde R W de Jong, Lydia Visser, Gerwin Huls, et al.
Annals of Hematology|September 3, 2021
The anemia-independent impact of myelodysplastic syndromes on health-related quality of lifeHanneke J C M Wouters, Annette Conrads-Frank, Karin A Koinig, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Hemasphere|September 18, 2023
Clonal Hematopoiesis Defined by Somatic Mutations Infrequently Co-occurs With Mosaic Loss of the Y Chromosome in a Population-based CohortPriscilla Kamphuis, Isabelle A van Zeventer, Aniek O de Graaf, et al.
Haematologica|December 11, 2025
Potent synergy of DHODH and SREBP inhibition in acute myeloid leukemia via disruption of cholesterol and lipid metabolismShanna M Hogeling, Dominique Sternadt, Nikita La Rose, et al.
Transplantation and Cellular Therapy|May 13, 2024
Improved Outcome of Allogeneic Transplantation in Older Patients Treated for Myeloid Malignancies Using Post-Transplantation Cyclophosphamide and Reduced Duration of Immune SuppressionLinde M Morsink, Carin L E Hazenberg, Goda Choi, et al.
Leukemia Research|April 8, 2019
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patientsJacobien Hilberink, Carin Hazenberg, Eva van den Berg, et al.
Cancer Cell|May 5, 2023
Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general populationIsabelle A van Zeventer, Aniek O de Graaf, Jonas B Salzbrunn, et al.
Experimental Hematology & Oncology|March 30, 2024
VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responsesYusheng Lin, Ghizlane Choukrani, Lena Dubbel, et al.
Plos Medicine|June 7, 2019
Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort studyMichele F Eisenga, Maarten A De Jong, Peter Van der Meer, et al.
Blood Advances|August 30, 2021
Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortalityIsabelle A van Zeventer, Aniek O de Graaf, Melanie M van der Klauw, et al.
Plos One|March 1, 2018
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approachMathilde R W de Jong, Lydia Visser, Gerwin Huls, et al.
Annals of Hematology|September 3, 2021
The anemia-independent impact of myelodysplastic syndromes on health-related quality of lifeHanneke J C M Wouters, Annette Conrads-Frank, Karin A Koinig, et al.
Pageof 17